Abstract
Seven members of a family affected by hereditary antithrombin III deficiency were identified. The disorder was associated with recurrent spontaneous episodes of phlebitis, deep venous thrombosis, and pulmonary embolism in middle age. Danazol, a 17-alkyl derivative of ethinyl testosterone, which has been used to treat other antiprotease deficiency states, was assessed in the management of two men with antithrombin deficiency. In a dose of 600 mg a day danazol appeared to correct the antithrombin deficiency. This drug may provide a useful adjunct to anticoagulant treatment, particularly before surgery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carrell R. W., Jeppsson J. O., Laurell C. B., Brennan S. O., Owen M. C., Vaughan L., Boswell D. R. Structure and variation of human alpha 1-antitrypsin. Nature. 1982 Jul 22;298(5872):329–334. doi: 10.1038/298329a0. [DOI] [PubMed] [Google Scholar]
- EGEBERG O. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA. Thromb Diath Haemorrh. 1965 Jun 15;13:516–530. [PubMed] [Google Scholar]
- Fagerhol M. K., Abildgaard U., Bergsjo P., Jacobsen J. H. Oral contraceptives and low antithrombin-3 concentration. Lancet. 1970 May 30;1(7657):1175–1175. doi: 10.1016/s0140-6736(70)91248-1. [DOI] [PubMed] [Google Scholar]
- Fiessinger J. N., Aiach M. Stanazolol treatment in an AT III deficient patient. Thromb Haemost. 1980 Jun 18;43(2):183–183. [PubMed] [Google Scholar]
- Gadek J. E., Fulmer J. D., Gelfand J. A., Frank M. M., Petty T. L., Crystal R. G. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease. J Clin Invest. 1980 Jul;66(1):82–87. doi: 10.1172/JCI109838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gelfand J. A., Sherins R. J., Alling D. W., Frank M. M. Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med. 1976 Dec 23;295(26):1444–1448. doi: 10.1056/NEJM197612232952602. [DOI] [PubMed] [Google Scholar]
- Gralnick H. R., Rick M. E. Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease. N Engl J Med. 1983 Jun 9;308(23):1393–1395. doi: 10.1056/NEJM198306093082305. [DOI] [PubMed] [Google Scholar]
- Gyde O. H., Middleton M. D., Vaughan G. R., Fletcher D. J. Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses. Br Med J. 1978 Mar 11;1(6113):621–622. doi: 10.1136/bmj.1.6113.621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
- Odegard O. R., Lie M., Abildgaard U. Heparin cofactor activity measured with an amidolytic method. Thromb Res. 1975 Apr;6(4):287–294. doi: 10.1016/0049-3848(75)90078-x. [DOI] [PubMed] [Google Scholar]
- Prochownik E. V., Antonarakis S., Bauer K. A., Rosenberg R. D., Fearon E. R., Orkin S. H. Molecular heterogeneity of inherited antithrombin III deficiency. N Engl J Med. 1983 Jun 30;308(26):1549–1552. doi: 10.1056/NEJM198306303082601. [DOI] [PubMed] [Google Scholar]
- Walker I. D., Davidson J. F., Young P., Conkie J. A. Effect of anabolic steroids on plasma antithrombin III. alpha2 macroglobulin and alpha1 antitrypsin levels. Thromb Diath Haemorrh. 1975 Sep 30;34(1):106–114. [PubMed] [Google Scholar]
- Winter J. H., Fenech A., Bennett B., Douglas A. S. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency. Br J Haematol. 1984 Jul;57(3):527–537. doi: 10.1111/j.1365-2141.1984.tb02927.x. [DOI] [PubMed] [Google Scholar]
- Winter J. H., Fenech A., Ridley W., Bennett B., Cumming A. M., Mackie M., Douglas A. S. Familial antithrombin III deficiency. Q J Med. 1982;51(204):373–395. [PubMed] [Google Scholar]